Solid Biosciences Inc (NAS:SLDB)
$ 9.07 +0.0050 (+0.06%) Market Cap: 972.53 Mil Enterprise Value: 615.01 Mil PE Ratio: 0 PB Ratio: 2.55 GF Score: 34/100

Solid Biosciences Inc at JPMorgan Healthcare Conference Transcript

Jan 14, 2026 / 01:15AM GMT
Release Date Price: $5.81 (+12.60%)
Anupam Rama
JPMorgan Chase & Co - Analyst

Welcome, everyone, to the 44th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I am one of the senior biotech analysts here at JPMorgan. I'm joined by my squad, Rati Pinge, Priyanka Grover, Joyce Zhou.

Our next presenting company is Solid Biosciences. And presenting on behalf of the company, we have CEO, Bo Cumbo.

Alexander Cumbo
Solid Biosciences Inc - President, Chief Executive Officer, Director

Yes. Thank you, Anupam. Thank you, JPMorgan, for the invitation. It's good to see all the friendly faces in the audience today and those who are attending. Before I start, the forward-looking statements, I'll give you -- I'm going to pause on the forward-looking statements and tell you a little story.

Before we actually started the presentation, two of our attorneys come up to me and talk about, are you excited about JPMorgan?

And I'm like, oh, great. What are you going to say? Well, I'm going to tell you about everything that's going on. We've dosed 33 patients, all safe, no

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot